EFFECT OF PIOGLITAZONE TREATMENT ON THE PROGRESSION OF IMPAIRED GLUCOSE TOL T2DM

吡格列酮治疗对 T2DM 血糖受损进展的影响

• 批准号: 7608438
• 负责人: Stephen colgan Clement
• 金额: $ 8.77万
• 依托单位: GEORGETOWN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-05-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7608438
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Development; Funding; Glucose; Grant; Individual; Institution; Non-Insulin-Dependent Diabetes Mellitus; Pioglitazone; Research; Research Personnel; Resources; Source; United States National Institutes of Health; impaired glucose tolerance; prevent

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is an examination of whether treatment of individuals with impaired glucose tolerance with pioglitazone can prevent or delay the development of type 2 diabetes mellitus.

这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究旨在探讨吡格列酮治疗糖耐量受损患者是否可以预防或延缓2型糖尿病的发生。